Physiomics Company

Physiomics plc combines systems biology with cutting edge mathematics to develop models that streamline the drug discovery and development process. Virtual Tumour, the company’s lead service, is used to optimise the dosing and scheduling of oncology drugs in pre-clinical and clinical trials. This optimisation improves the efficacy of combinations and streamlines the drug development process.
Technology: Drug Discovery
Industry: Personalized Medicine
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 2002
Employees Number: Undisclosed
Funding Status: IPO

Visit Website
Register and Claim Ownership